House Dems Float Compounding Oversight Bill

Law360, New York (December 6, 2012, 6:25 PM EST) -- Two House Democrats on Wednesday introduced a bill that would require compounding pharmacies to register with the U.S. Food and Drug Administration and to use compound-specific labeling, a move they said would prevent incidents like the recent fatal meningitis outbreak.

Reps. Rosa DeLauro, D-Conn., and Nita Lowey, D-N.Y., said their bill would “improve the failed regulatory framework currently governing compounding pharmacies.”

“I wish this legislation were not necessary, but recent, tragic events have proven that it is,” DeLauro said in a statement. “The actions of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.